再生医学公司Orthocell Ltd宣布，已将其在海洋生物医药公司Marine Biomedical的持股比例提升至11.7%。此次增持使Orthocell对该公司的累计投资总额达到105万澳元。该举措进一步深化了双方在创新生物医学领域的战略合作，有望为Orthocell的产品管线注入新的技术资源。
再生医学公司Orthocell Ltd宣布，已将其在海洋生物医药公司Marine Biomedical的持股比例提升至11.7%。此次增持使Orthocell对该公司的累计投资总额达到105万澳元。该举措进一步深化了双方在创新生物医学领域的战略合作，有望为Orthocell的产品管线注入新的技术资源。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.